130 related articles for article (PubMed ID: 30732948)
61. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
[TBL] [Abstract][Full Text] [Related]
62. [Cetuximab in head and neck squamous cell carcinoma: a systematic review and Meta-analysis].
Song Q; Li X; Li B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):67-75. PubMed ID: 25966559
[TBL] [Abstract][Full Text] [Related]
63. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
64. Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma.
Joo YH; Cho KJ; Park JO; Nam IC; Kim CS; Cho HJ; Kim MS
Acta Otolaryngol; 2013 Oct; 133(10):1104-9. PubMed ID: 24032573
[TBL] [Abstract][Full Text] [Related]
65. Socio-economic factors and stage at presentation of head and neck cancer patients in Ottawa, Canada: a logistic regression analysis.
Johnson S; Corsten MJ; McDonald JT; Chun J
Oral Oncol; 2010 May; 46(5):366-8. PubMed ID: 20308010
[TBL] [Abstract][Full Text] [Related]
66. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
[TBL] [Abstract][Full Text] [Related]
67. Gene-environment interaction and susceptibility in head and neck cancer patients and in their first-degree relatives: a study of Northeast Indian population.
Choudhury JH; Ghosh SK
J Oral Pathol Med; 2015 Aug; 44(7):495-501. PubMed ID: 25167831
[TBL] [Abstract][Full Text] [Related]
68. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
69. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
70. Association between the Processed Dietary Pattern and Tumor Staging in Patients Newly Diagnosed with Head and Neck Squamous Cell Carcinoma.
Lima ACDS; Ferreira TJ; Campos ADS; Matida LM; Castro MBT; Freitas-Vilela AA; Horst MA
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900268
[TBL] [Abstract][Full Text] [Related]
71. Influence of travel burden on tumor classification and survival of head and neck cancer patients.
Vahl JM; von Witzleben A; Welke C; Doescher J; Theodoraki MN; Brand M; Schuler PJ; Greve J; Hoffmann TK; Laban S
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4535-4543. PubMed ID: 33877433
[TBL] [Abstract][Full Text] [Related]
72. Travel the world while earning CPD.
Br Dent J; 2022 May; 232(9):665. PubMed ID: 35562469
[No Abstract] [Full Text] [Related]
73. Association of chronic liver disease mortality and patient travel time.
Gaddipati N; Chyou D; Blandon C; Goldberg DS
Liver Transpl; 2024 Mar; ():. PubMed ID: 38471005
[No Abstract] [Full Text] [Related]
74. Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma.
Han B; Li S; Huang S; Huang J; Wu T; Chen X
PeerJ; 2023; 11():e16197. PubMed ID: 37846311
[TBL] [Abstract][Full Text] [Related]
75. The Relation Between Travel Distance and Overall Survival for HPV-Associated Cancers in a High-Burden State.
Gopalani SV; Dao HD; Ford L; Campbell JE; Peck JD; Chen S; Comiford A; Etzold N; Janitz AE
J Registry Manag; 2023; 50(1):11-18. PubMed ID: 37577287
[TBL] [Abstract][Full Text] [Related]
76. The impact of distance traveled and rurality on the clinical course of head and neck cancer.
Debick N; Gemmiti A; Ryan J
Laryngoscope Investig Otolaryngol; 2023 Jun; 8(3):651-658. PubMed ID: 37342104
[TBL] [Abstract][Full Text] [Related]
77. Disparities in Oral Cancer Stage at Presentation in a High HIV Prevalence Setting In Sub-Saharan Africa.
Motlokwa PK; Tsima BM; Martei YM; Ralefala T; Galebole F; Stephens-Shields AJ; Grover S; Gross R
JCO Glob Oncol; 2022 Aug; 8():e2100439. PubMed ID: 35981280
[TBL] [Abstract][Full Text] [Related]
78. Socioeconomic disparities between oral cavity cancer patients in Germany.
Muallah D; Matschke J; Muallah S; Klimova A; Kroschwald LM; Schröder TA; Lauer G; Haim D
Front Public Health; 2022; 10():831479. PubMed ID: 35937274
[TBL] [Abstract][Full Text] [Related]
79. Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients.
Emerson MA; Farquhar DR; Lenze NR; Sheth S; Mazul AL; Zanation AM; Hackman TG; Weissler MC; Zevallos JP; Yarbrough WG; Brennan P; Abedi-Ardekani B; Olshan AF
Head Neck; 2022 Apr; 44(4):823-834. PubMed ID: 35044015
[TBL] [Abstract][Full Text] [Related]
80. Targets for improving disparate head and neck cancer outcomes in the low-income population.
Entezami P; Thomas B; Mansour J; Asarkar A; Nathan CA; Pang J
Laryngoscope Investig Otolaryngol; 2021 Dec; 6(6):1481-1488. PubMed ID: 34938891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
